Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02432378
Title Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines
Recruitment Suspended
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

ovarian carcinosarcoma

peritoneum cancer

fallopian tube carcinosarcoma

Therapies

Celecoxib + Cisplatin + Interferon alpha-2b + Rintatolimod

Celecoxib + Cisplatin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.